Evidence map›Paper›PMID 27243004›Full record

ArticleFrontiers in cell and developmental biology2016

N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa.

Martina E C Bluhm, Viktoria A F Schneider, Ingo Schäfer, Stefania Piantavigna, Tina Goldbach, Daniel Knappe, Peter Seibel, Lisandra L Martin, Edwin J A Veldhuizen, Ralf Hoffmann

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Frontiers in chemistry · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Martina E C BluhmFaculty of Chemistry and Mineralogy, Institute of Bioanalytical Chemistry, Universität LeipzigLeipzig, Germany; Center for Biotechnology and Biomedicine, Universität LeipzigLeipzig, Germany.
Viktoria A F SchneiderDivision of Molecular Host Defence, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University Utrecht, Netherlands.
Ingo SchäferCenter for Biotechnology and Biomedicine, Universität LeipzigLeipzig, Germany; Molecular Cell Therapy, Faculty of Medicine, Universität LeipzigLeipzig, Germany.
Stefania PiantavignaSchool of Chemistry, Monash University Clayton, VIC, Australia.
Tina GoldbachFaculty of Chemistry and Mineralogy, Institute of Bioanalytical Chemistry, Universität LeipzigLeipzig, Germany; Center for Biotechnology and Biomedicine, Universität LeipzigLeipzig, Germany.
Daniel KnappeFaculty of Chemistry and Mineralogy, Institute of Bioanalytical Chemistry, Universität LeipzigLeipzig, Germany; Center for Biotechnology and Biomedicine, Universität LeipzigLeipzig, Germany.
Peter SeibelCenter for Biotechnology and Biomedicine, Universität LeipzigLeipzig, Germany; Molecular Cell Therapy, Faculty of Medicine, Universität LeipzigLeipzig, Germany.
Lisandra L MartinSchool of Chemistry, Monash University Clayton, VIC, Australia.
Edwin J A VeldhuizenDivision of Molecular Host Defence, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University Utrecht, Netherlands.
Ralf HoffmannFaculty of Chemistry and Mineralogy, Institute of Bioanalytical Chemistry, Universität LeipzigLeipzig, Germany; Center for Biotechnology and Biomedicine, Universität LeipzigLeipzig, Germany.
Leipzig University · DEMonash University · AUUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Gram-negative bacterium Pseudomonas aeruginosa is a life-threatening nosocomial pathogen due to its generally low susceptibility toward antibiotics. Furthermore, many strains have acquired resistance mechanisms requiring new antimicrobials with novel mechanisms to enhance treatment options. Proline-rich antimicrobial peptides, such as the apidaecin analog Api137, are highly efficient against various Enterobacteriaceae infections in mice, but less active against P. aeruginosa in vitro. Here, we extended our recent work by optimizing lead peptides Api755 (gu-OIORPVYOPRPRPPHPRL-OH; gu = N,N,N',N'-tetramethylguanidino, O = L-ornithine) and Api760 (gu-OWORPVYOPRPRPPHPRL-OH) by incorporation of Ile-Orn- and Trp-Orn-motifs, respectively. Api795 (gu-O(IO)2RPVYOPRPRPPHPRL-OH) and Api794 (gu-O(WO)3RPVYOPRPRPPHPRL-OH) were highly active against P. aeruginosa with minimal inhibitory concentrations of 8-16 and 8-32 μg/mL against Escherichia coli and Klebsiella pneumoniae. Assessed using a quartz crystal microbalance, these peptides inserted into a membrane layer and the surface activity increased gradually from Api137, over Api795, to Api794. This mode of action was confirmed by transmission electron microscopy indicating some membrane damage only at the high peptide concentrations. Api794 and Api795 were highly stable against serum proteases (half-life times >5 h) and non-hemolytic to human erythrocytes at peptide concentrations of 0.6 g/L. At this concentration, Api795 reduced the cell viability of HeLa cells only slightly, whereas the IC50 of Api794 was 0.23 ± 0.09 g/L. Confocal fluorescence microscopy revealed no colocalization of 5(6)-carboxyfluorescein-labeled Api794 or Api795 with the mitochondria, excluding interactions with the mitochondrial membrane. Interestingly, Api795 was localized in endosomes, whereas Api794 was present in endosomes and the cytosol. This was verified using flow cytometry showing a 50% higher uptake of Api794 in HeLa cells compared with Api795. The uptake was reduced for both peptides by 50 and 80%, respectively, after inhibiting endocytotic uptake with dynasore. In summary, Api794 and Api795 were highly active against P. aeruginosa in vitro. Both peptides passed across the bacterial membrane efficiently, most likely then disturbing the ribosome assembly, and resulting in further intracellular damage. Api795 with its IOIO-motif, which was particularly active and only slightly toxic in vitro, appears to represent a promising third generation lead compound for the development of novel antibiotics against P. aeruginosa.

Indexed as

antibioticapidaecincell uptakeconfocal fluorescence microscopyproline-rich antimicrobial peptide (PrAMP)quartz crystal microbalance (QCM)transmission electron microscopy (TEM)

Identifiers

PMID27243004
PMCPMC4861708
OpenAlexW2347118269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.